Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Albertsson

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer PatientsElin Cederkrantz, Håkan Andersson, Peter Bernhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Intraperitoneal α-Emitting Radioimmunotherapy with <sup>211</sup>At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose EstimationsAndreas Hallqvist, Karin Bergmark, Tom Bäck, et al.
International Journal of Cardiology|January 12, 2015
Low socioeconomic status of a patient's residential area is associated with worse prognosis after acute myocardial infarction in SwedenGöran Bergström, Björn Redfors, Oskar Angerås, et al.
Journal of the American Heart Association|July 15, 2020
Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty RegistrySebastian Völz, Petur Petursson, Jacob Odenstedt, et al.
Acute Cardiac Care|March 28, 2014
Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?Niklas Bergh, Oskar Angerås, Per Albertsson, et al.
Molecular Pharmaceutics|July 4, 2019
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo BehaviorYana Dekempeneer, Tom Bäck, Emma Aneheim, et al.
Medical Physics|January 12, 2018
MR and CT data with multiobserver delineations of organs in the pelvic area-Part of the Gold Atlas projectTufve Nyholm, Stina Svensson, Sebastian Andersson, et al.
European Heart Journal|March 10, 2019
Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty RegistryBjorn Redfors, Christian Dworeck, Inger Haraldsson, et al.
Journal of the American College of Cardiology|March 19, 2013
Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Marieke L Fokkema, Stefan K James, Per Albertsson, et al.
European Heart Journal. Acute Cardiovascular Care|September 14, 2019
Prognostic impact of percutaneous coronary intervention in octogenarians with non-ST elevation myocardial infarction: A report from SWEDEHEARTSebastian Völz, Petur Petursson, Oskar Angerås, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer PatientsElin Cederkrantz, Håkan Andersson, Peter Bernhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Intraperitoneal α-Emitting Radioimmunotherapy with <sup>211</sup>At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose EstimationsAndreas Hallqvist, Karin Bergmark, Tom Bäck, et al.
International Journal of Cardiology|January 12, 2015
Low socioeconomic status of a patient's residential area is associated with worse prognosis after acute myocardial infarction in SwedenGöran Bergström, Björn Redfors, Oskar Angerås, et al.
Journal of the American Heart Association|July 15, 2020
Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty RegistrySebastian Völz, Petur Petursson, Jacob Odenstedt, et al.
Acute Cardiac Care|March 28, 2014
Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?Niklas Bergh, Oskar Angerås, Per Albertsson, et al.
Molecular Pharmaceutics|July 4, 2019
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo BehaviorYana Dekempeneer, Tom Bäck, Emma Aneheim, et al.
Medical Physics|January 12, 2018
MR and CT data with multiobserver delineations of organs in the pelvic area-Part of the Gold Atlas projectTufve Nyholm, Stina Svensson, Sebastian Andersson, et al.
European Heart Journal|March 10, 2019
Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty RegistryBjorn Redfors, Christian Dworeck, Inger Haraldsson, et al.
Journal of the American College of Cardiology|March 19, 2013
Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Marieke L Fokkema, Stefan K James, Per Albertsson, et al.
European Heart Journal. Acute Cardiovascular Care|September 14, 2019
Prognostic impact of percutaneous coronary intervention in octogenarians with non-ST elevation myocardial infarction: A report from SWEDEHEARTSebastian Völz, Petur Petursson, Oskar Angerås, et al.
Pageof 11